Lotte Steuten | Deputy CEO
Office of Health Economics

Lotte Steuten is Currently the Deputy Chief Executive at the Office of Health Economics, and an Honorary Professor of Health Economics at City St George's, University of London, UK. Lotte brings a wealth of experience in driving strategic initiatives and building the evidence base for innovative payment models. With a proven track record of successful partnerships and collaborations, she is dedicated to advancing the orphan drug industry through evidence-based strategies and impactful dissemination efforts. Lotte's expertise lies in leveraging health economic insights to inform decision-making and shape policies that benefit patients incl. those with rare diseases, and populations more broadly. Her commitment to building the evidence base for novel payment models for high-value orphan drugs and promoting sustainability in healthcare systems motivates her to drive positive change for all stakeholders involved. Attendees can expect to gain valuable insights and practical guidance from Lotte's session at the World Orphan Drug Congress 2025, as she shares her expertise on pricing and payment of orphan drugs.